Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: A preliminary study

International Journal of Neuropsychopharmacology

Volumn 7, Issue 3, 2004, Pages 255-263

  Daban, Claire ^a   Krebs, Marie Odile ^a   Bourdel, Marie Chantal ^a   Willard, Dominique ^a   Loo, Henri ^a   Olié, Jean Pierre ^a   Poirier, Marie France ^a   Amado, Isabelle ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Alertness; Atypical neuroleptics; Choice reaction time; Schizophrenia; Visual orienting

Indexed keywords

AMISULPRIDE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ALERTNESS; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REACTION TIME; SCHIZOPHRENIA; TASK PERFORMANCE; TREATMENT OUTCOME; VISUAL ORIENTATION;

ADULT; ANTIPSYCHOTIC AGENTS; AROUSAL; CUES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; ORIENTATION; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 4444329598     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004250     Document Type: Article

References (50)

1. Achten B, Fimm B, Kottenhoff R, Liebert M, Weis S, Kemeny S, Erberich SG, Willmes K, Sturm W (1999). A functional MRI study of covert and overt orienting of attention. Neural Plasticity (Suppl. 1), 176.
2. Addington J, Addington D (1999). Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin 25, 173-182.
3. Addington J, McCleary L, Munroe-Blum H (1998). Relationship between cognitive and social dysfunction en schizophrenia. Schizophrenia Research 34, 59-66.
4. Baxter RD, Liddle PF (1998). Neuropsychological deficits associated with schizophrenic syndromes. Schizophrenia Research 30, 239-249.
5. Boff KR, Lincoln JE (1988). Engineering Data Compendium: Human Perception and Performance, vol. 2. Writz-Patterson Air Force Base, OH: HG Amstrong Aerospace Medical Research Library.
6. Britton PG, Savage RD (1966). A short form of the WAIS for use with age. British Journal of Psychiatry 112, 417-418.
7. Carter CS, Robertson LC, Chaderjian MR, Celaya LJ, Nordahl, TE (1992). Attentional asymmetry in schizophrenia: controlled and automatic processes. Biological Psychiatry 31, 909-918.
8. Cassens G, Inglis AK, Appelbaum PS, Gutheil TG (1990). Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizoprenia Bulletin 16, 477-499.
9. Clark CR, Geffen GM, Geffen LB (1989). Cathecholamines and the covert of attention in humans. Neuropsychologia 27, 131-139.
10. Corbetta M, Miezin FM, Shulman GL, Petersen SE (1993). A PET study of visual attention. Journal of Neuroscience 13, 1202-1226.
11. Corbetta M, Kincade JM, Ollinger JM, McAvoy MP, Shulman GL (2000). Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nature Neuroscience 3, 292-297.
12. Coull JT (1998). Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Progress in Neurobiology 55, 343-361.
13. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766-771.
14. Fuller R, Jahanshahi M (1999). Impairment of willed actions and use of advance information for movement preparation in schizophrenia. Journal of Neurology, Neurosurgery, and Psychiatry 66, 502-509.
15. Gold JM, Randolph C, Coppola R, Carpenter CJ, Goldberg TE, Weinberger R (1992). Visual orienting in schizophrenia. Schizophrenia Research 7, 203-209.
16. Hong KS, Kim JG, Koh HJ, Koo MS, Kim JH, Lee D, Kim E (2002). Effects of risperidone on information processing and attention in first-episode schizophrenia. Schizophrenia Research 53, 7-16.
17. Kay SR, Opler LA (1987). Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
18. Keefe RS, Silva SG, Perkins DO, Lieberman JA (1999). The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophrenia Bulletin 25, 201-222.
19. Kremen WS, Seidman LJ, Faraone SV, Tsuang MT (2001). Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers. Biological Psychiatry 50, 453-462.
20. Krieger S, Lis S, Gallhofer B (2001). Cognitive subprocesses and schizophrenia. A. Reaction-time decomposition. Acta Psychiatrica Scandinavica (Suppl.) 408, 18-27.
21. Lépine JP, Piron JJ, Chapotot E (1989). Factor analysis of the PANSS in schizophrenic patients. Proceeding of the 8th International Congress of Psychiatry; 12-19 October 1989 Athens, Greece. In: Psychiatry Today: Accomplishments and Promises [Abstract 3232]. Amsterdam: Excerpta Medica.
22. Lussier I, Stip E (2001). Memory and attention deficits in drug naïve patients with schizophrenia. Schizophrenia Research 48, 45-55.
23. Maruff P, Hay D, Malone V, Currie J (1995). Asymmetries in the covert orienting of visual spatial attention in schizophrenia. Neuropsychologia 33, 1205-1223.
24. Meltzer HY, McGurk S (1999). The effects of clozapine, ripseridone and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 25, 233-255.
25. Nestor PG, Faux SF, McCarley RW (1992). Attentional cues in chronic schizophrenia: abnormal disengagement of attention. Journal of Abnormal Psychology 101, 682-689.
26. Ngan E, Liddle P (2000). Reaction time, symptom profiles and course of illness in schizophrenia. Schizophrenia Research 46, 195-201.
27. Nuechterlein KH (1977). Reaction time and attention in schizophrenia: a critical evaluation of the data and theories. Schizophrenia Bulletin 3, 373-428.
28. Nurnberger JI, Blehar MC, Kaufmann CA (1994). Diagnostic interview for genetic studies: rational, unique features and training. Archives of General Psychiatry 51, 849-859.
29. Park S, Puschel J, Sauter BH, Rentsch M, Hell D (2002). Spatial selective attention and inhibition in schizophrenia patients during acute psychosis and at 4-month follow-up. Biological Psychiatry 51, 498-506.
30. Posner MI (1986). Chronometric Explorations of Mind. New York: Oxford University Press.
31. Posner MI, Cohen Y (1984). Components of visual orientation. In: Bouma H, Bouwhuis DG (Eds.), Attention and Performance (pp. 531-556). Hillsdale, NJ: Erlbaum.
32. Posner MI, Early TS, Reiman E (1988). Asymmetries in hemispheric control of attention in schizophrenia. Archives of General Psychiatry 45, 814-821.
33. Posner MI, Walker JA, Friedrich F, Rafal RD (1984). Effects of parietal injury in covert orienting of attention. Journal of Neuroscience 4, 1863-1874.
34. Potkin SG, Swanson JM, Urbanchek M, Carreon D, Bravo G (1989). Lateralized deficits in covert shifts of visual attention in chronic and never-medicated schizophrenics compared with normal controls. Schizophrenia Research 2, 95.
35. Purdon SE (1999) Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophrenia Research 1, 35 (Suppl.) S51-S60.
36. Purdon SE, Jones B, Stip E, Labelle A, Addington D, David S, Breier A, Tollefson G (2000). Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone or haloperidone. Archives of General Psychiatry 57, 249-258.
37. Quintana J, Wong T, Ortiz-Portillo E, Kovalik E, Davidson T, Marder SR, Mazziotta JC (2003). Prefrontal-posterior parietal networks in schizophrenia: primary dysfunctions and secondary compensations. Biological Psychiatry 53, 12-24.
38. Robinson DL, Kertzman C (1995). Covert orienting of attention in macaques. III. Contributions of the superior colliculus. Journal of Neurophysiology 74, 713-721.
39. Rodnick EH, Shakow D (1940). Set in the schizophrenic as measured by a composite reaction time index. American Journal of Psychiatry 97, 214-225.
40. Rollnik JD, Borsutzky M, Huber TJ, Mogk H, Seifert J, Emrich HM, Schneider U (2002). Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. Neuropsychobiology 45, 74-80.
41. Sapir A, Henik A, Dobrusin M, Hochman EY (2001). Attentional asymmetry in schizophrenia: disengagement and inhibition of return deficits. Neuropsychology 15, 361-370.
42. Simpson G, Angus J (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 212 (Suppl.), 11-19.
43. Spohn HE, Strauss ME (1989). Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology 98, 367-368.
44. Steinmetz MA, Constantinidis C (1995). Neurophysiological evidence for a role of posterior parietal cortex in redirecting visual attention. Cerebral Cortex 5, 448-456.
45. Stip E, Lussier I, Lalonde P, Luyet A, Fabian J (1999). Selective attention and schizophrenia before the administration of neuroleptics. L'Encéphale 25, 260-264.
46. Strauss ME, Novakovic T, Tien AY, Bylsma F, Pearlson GD (1991). Disengagement of attention in schizophrenia. Psychiatry Research 37, 139-146.
47. Sturm W, Willmes K (2001). On the functional neuroanatomy of intrinsic and phasic alertness. Neuroimage 14 (1 Pt 2), S76-S84.
48. Weiser M, Shneider-Beeri M, Nakash N, Brill N, Bawnik O, Reiss S, Hocherman S, Davidson M (2000). Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS? Schizophrenia Research 46, 81-89.
49. Witte EA, Marrocco RT (1997). Alteration brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology 132, 315-323.
50. Zahn TP, Pickar D, Haier RJ (1994). Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophrenia Research 13, 133-144.